1 – 50 of 50
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
GDNF and Parkinson's Disease : Where Next? A Summary from a Recent Workshop
(
- Contribution to journal › Article
- 2017
-
Mark
Exendin-4 treatment improves LPS-induced depressive-like behavior without affecting pro-inflammatory cytokines
(
- Contribution to journal › Article
- 2016
-
Mark
Identification of multiple QTLs linked to neuropathology in the engrailed-1 heterozygous mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?
(
- Contribution to journal › Article
- 2015
-
Mark
A cell culture model for monitoring α-synuclein cell-to-cell transfer.
(
- Contribution to journal › Article
-
Mark
Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro.
(
- Contribution to journal › Article
-
Mark
Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Long-term clinical outcome of fetal cell transplantation for Parkinson disease : two case reports
(
- Contribution to journal › Article
- 2013
-
Mark
Microchannel Acoustophoresis does not Impact Survival or Function of Microglia, Leukocytes or Tumor Cells.
(
- Contribution to journal › Article
-
Mark
Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Nonsteroidal Selective Androgen Receptor Modulators and Selective Estrogen Receptor β Agonists Moderate Cognitive Deficits and Amyloid-β Levels in a Mouse Model of Alzheimer's Disease.
(
- Contribution to journal › Article
-
Mark
Adsorption of α-Synuclein to Supported Lipid Bilayers: Positioning and Role of Electrostatics.
(
- Contribution to journal › Article
-
Mark
What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
(
- Contribution to journal › Article
-
Mark
α-Synuclein: The Long Distance Runner.
(
- Contribution to journal › Article
-
Mark
Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice.
(
- Contribution to journal › Article
-
Mark
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
(
- Contribution to journal › Scientific review
-
Mark
NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
(
- Contribution to journal › Article
- 2012
-
Mark
Neuronal Properties, In Vivo Effects, and Pathology of a Huntington's Disease Patient-Derived Induced Pluripotent Stem Cells
(
- Contribution to journal › Article
-
Mark
Can Parkinson's disease pathology be propagated from one neuron to another?
(
- Contribution to journal › Article
-
Mark
Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
2012) In European Journal of Pharmacology(
- Contribution to journal › Article
-
Mark
Neuropathology in transplants in Parkinson's disease: Implications for disease pathogenesis and the future of cell therapy.
(
- Contribution to journal › Article
- 2011
-
Mark
Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
(
- Contribution to journal › Article
-
Mark
Neurogenesis In The R6/2 Mouse Model Of Huntington'S Disease Is Impaired At The Level Of Neurod1
(
- Contribution to journal › Article
-
Mark
Stage-Specific Modulation of Cortical Neuronal Development by Mmu-miR-134
(
- Contribution to journal › Article
-
Mark
Systemic administration of Neuregulin-1ß(1) protects dopaminergic neurons in a mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease
(
- Contribution to journal › Article
-
Mark
Membrane Interaction of α-Synuclein in Different Aggregation States
(
- Contribution to journal › Article
-
Mark
The executioners sing a new song: killer caspases activate microglia
(
- Contribution to journal › Scientific review
-
Mark
A deadly spread: cellular mechanisms of α-synuclein transfer.
(
- Contribution to journal › Article
-
Mark
Reduced neurogenesis in the rat hippocampus following high fructose consumption.
(
- Contribution to journal › Article
-
Mark
Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
Can alpha-synuclein be targeted in novel therapies for Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Caspase signalling controls microglia activation and neurotoxicity.
(
- Contribution to journal › Article
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
- 2010
-
Mark
Nitric Oxide Stimulates the Proliferation of Neural Stem Cells Bypassing the Epidermal Growth Factor Receptor
(
- Contribution to journal › Article
-
Mark
Foxa2 and Nurr1 Synergistically Yield A9 Nigral Dopamine Neurons Exhibiting Improved Differentiation, Function, and Cell Survival
(
- Contribution to journal › Article
-
Mark
Neural grafting in Parkinson's disease: problems and possibilities
(
- Contribution to journal › Scientific review
-
Mark
Characterization of Lewy Body Pathology in 12-and 16-Year Old Intrastriatal Mesencephalic Grafts Surviving in a Patient with Parkinson's Disease
(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Brain injury activates microglia that induce neural stem cell proliferation ex vivo and promote differentiation of neurosphere-derived cells into neurons and oligodendrocytes
(
- Contribution to journal › Article
-
Mark
A simple method for large-scale generation of dopamine neurons from human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
Prion-like transmission of protein aggregates in neurodegenerative diseases.
(
- Contribution to journal › Scientific review
-
Mark
Cell transplantation in Parkinson's disease: problems and perspectives.
(
- Contribution to journal › Article
-
Mark
Are synucleinopathies prion-like disorders?
(
- Contribution to journal › Article
-
Mark
GABAergic Differentiation Induced by Mash1 Is Compromised by the bHLH Proteins Neurogenin2, NeuroD1, and NeuroD2.
(
- Contribution to journal › Article